关注
Krisztina Papp-Wallace
Krisztina Papp-Wallace
Operations Manager, JMI Laboratories, a subsidiary of Element Materials Technology
在 case.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Carbapenems: past, present, and future
KM Papp-Wallace, A Endimiani, MA Taracila, RA Bonomo
Antimicrobial agents and chemotherapy 55 (11), 4943-4960, 2011
18252011
New β-lactamase inhibitors: a therapeutic renaissance in an MDR world
SM Drawz, KM Papp-Wallace, RA Bonomo
Antimicrobial agents and chemotherapy 58 (4), 1835-1846, 2014
3472014
Manganese transport and the role of manganese in virulence
KM Papp-Wallace, ME Maguire
Annu. Rev. Microbiol. 60 (1), 187-209, 2006
3052006
Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae?
S Marshall, AM Hujer, LJ Rojas, KM Papp-Wallace, RM Humphries, ...
Antimicrobial agents and chemotherapy 61 (4), 10.1128/aac. 02243-16, 2017
2782017
Inhibitor resistance in the KPC-2 β-lactamase, a preeminent property of this class A β-lactamase
KM Papp-Wallace, CR Bethel, AM Distler, C Kasuboski, M Taracila, ...
Antimicrobial agents and chemotherapy 54 (2), 890-897, 2010
2232010
New β-lactamase inhibitors in the clinic
KM Papp-Wallace, RA Bonomo
Infectious Disease Clinics 30 (2), 441-464, 2016
1882016
Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?
F Perez, NG El Chakhtoura, KM Papp-Wallace, BM Wilson, RA Bonomo
Expert opinion on pharmacotherapy 17 (6), 761-781, 2016
1802016
Prevalence and antibiotic resistance patterns of diarrheagenic Escherichia coli isolated from adolescents and adults in Hamedan, Western Iran
MY Alikhani, SH Hashemi, MM Aslani, S Farajnia
Iranian journal of microbiology 5 (1), 42, 2013
162*2013
Unexpected challenges in treating multidrug-resistant Gram-negative bacteria: resistance to ceftazidime-avibactam in archived isolates of Pseudomonas aeruginosa
ML Winkler, KM Papp-Wallace, AM Hujer, TN Domitrovic, KM Hujer, ...
Antimicrobial agents and chemotherapy 59 (2), 1020-1029, 2015
1472015
Strategic approaches to overcome resistance against Gram-negative pathogens using β-lactamase inhibitors and β-lactam enhancers: activity of three novel diazabicyclooctanes WCK …
KM Papp-Wallace, NQ Nguyen, MR Jacobs, CR Bethel, MD Barnes, ...
Journal of medicinal chemistry 61 (9), 4067-4086, 2018
1282018
Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop
ML Winkler, KM Papp-Wallace, RA Bonomo
Journal of antimicrobial chemotherapy 70 (8), 2279-2286, 2015
1272015
The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections
KM Papp-Wallace
Expert opinion on pharmacotherapy 20 (17), 2169-2184, 2019
1212019
WCK 5107 (zidebactam) and WCK 5153 are novel inhibitors of PBP2 showing potent “β-lactam enhancer” activity against Pseudomonas aeruginosa, including multidrug-resistant …
B Moya, IM Barcelo, S Bhagwat, M Patel, G Bou, KM Papp-Wallace, ...
Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 02529-16, 2017
1212017
Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae
A Lupo, KM Papp-Wallace, P Sendi, RA Bonomo, A Endimiani
Diagnostic microbiology and infectious disease 77 (3), 179-194, 2013
1172013
Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance
RR Watkins, KM Papp-Wallace, SM Drawz, RA Bonomo
Frontiers in microbiology 4, 392, 2013
1082013
Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam
KM Papp-Wallace, ML Winkler, MA Taracila, RA Bonomo
Antimicrobial agents and chemotherapy 59 (7), 3710-3717, 2015
1042015
Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic …
MD Barnes, ML Winkler, MA Taracila, MG Page, E Desarbre, ...
MBio 8 (5), 10.1128/mbio. 00528-17, 2017
1022017
Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei
DA Rholl, KM Papp-Wallace, AP Tomaras, ML Vasil, RA Bonomo, ...
Frontiers in microbiology 2, 139, 2011
1012011
Resistance to novel β-lactam–β-lactamase inhibitor combinations: the “price of progress”
KM Papp-Wallace, AR Mack, MA Taracila, RA Bonomo
Infectious Disease Clinics 34 (4), 773-819, 2020
952020
Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study
NP Krishnan, NQ Nguyen, KM Papp-Wallace, RA Bonomo, ...
PloS one 10 (9), e0136813, 2015
922015
系统目前无法执行此操作,请稍后再试。
文章 1–20